HH Linctus-Ex Expectorant is a combination oral syrup formulated to alleviate symptoms associated with productive cough and bronchial congestion. It contains Ambroxol (15 mg/5 ml), Guaifenesin (50 mg/5 ml), and Terbutaline (1.25 mg/5 ml), each contributing to its multifaceted therapeutic action. Ambroxol acts as a mucolytic agent, facilitating the breakdown and clearance of viscous mucus from the respiratory tract, thereby improving airway patency. Guaifenesin serves as an expectorant, promoting increased secretion of respiratory tract fluids, which aids in loosening phlegm and enhancing productive cough. Terbutaline, a selective beta-2 adrenergic receptor agonist, provides bronchodilation by relaxing bronchial smooth muscle, thus reducing airway resistance and easing breathing difficulties. This combination is indicated for the symptomatic treatment of acute and chronic respiratory conditions characterized by excessive mucus production and bronchospasm, such as bronchitis, asthma, and chronic obstructive pulmonary disease (COPD). HH Linctus-Ex should be used under medical supervision, with dosage adjusted according to patient age and clinical condition. Caution is advised in patients with cardiovascular disorders, hyperthyroidism, or hypersensitivity to any component. Adverse effects may include gastrointestinal discomfort, tremors, or palpitations. It is contraindicated in patients with known hypersensitivity to Ambroxol, Guaifenesin, or Terbutaline.